Featured Research

from universities, journals, and other organizations

Vaccine Against Childhood Pneumonia Shows Promise

Date:
June 1, 2005
Source:
Lancet
Summary:
A vaccine against pneumonia and invasive pneumococcal disease, a severe form of bacterial infection, can substantially reduce hospital admissions and improve the survival of children in developing countries, concludes a trial published in the March 26, 2005 issue of THE LANCET. The authors believe the vaccine should be made available to children in Africa, where rates of severe invasive pneumococcal disease are up to ten times higher than in industrialised countries.

A vaccine against pneumonia and invasive pneumococcal disease, a severe form of bacterial infection, can substantially reduce hospital admissions and improve the survival of children in developing countries, concludes a trial published in the March 26, 2005 issue of THE LANCET. The authors believe the vaccine should be made available to children in Africa, where rates of severe invasive pneumococcal disease are up to ten times higher than in industrialised countries.

Related Articles


Pneumonia causes an estimated 19% of the 10 million childhood deaths worldwide annually. The bacterium Streptococcus pneumoniae is responsible for up to half of all cases of severe childhood pneumonia in developing countries. It also causes serious bloodstream infections, meningitis, and otitis media (inflammation of the middle ear).

Felicity Cutts (Medical Research Council, UK and WHO) and colleagues recruited children aged 6-51 weeks in The Gambia from August 2000 to February 2003. Children were randomly assigned to receive either, three doses of diphtheria-tetanus-pertussis-Haemophilus influenzae serotype b vaccine as a control (8719), or three doses of this tetravalent vaccine mixed with a nine-valent pneumococcal conjugate vaccine (8718), with intervals of at least 25 days between doses. 333 of the 8189 children given the pneumococcal vaccine had an episode of pneumonia confirmed by chest x-ray compared with 513 of 8151 in the control group. The vaccine reduced the first episode of pneumonia diagnosed by chest x-ray by 37% and reduced admissions to hospital by 15%. Disease caused by the types of pneumococcus bacteria in the vaccine was lowered by 77% and overall child mortality by 16%. The vaccine also had a good safety profile.

Professor Cutts comments: "The trial results are highly promising, and provide us with a clearer picture of the pneumococcal disease burden in Africa. In the control group, 65% of invasive disease episodes were of serotypes contained in the nine-valent trial vaccine, and 48% were of serotypes in the licensed seven-valent vaccine. Vaccines containing more serotypes could have an even greater effect. Identification of means to make pneumococcal conjugate vaccines available as soon as possible to children who need them most is extremely important." (Quote by e-mail; does not appear in published paper)

In an accompanying commentary, Marilla Lucero and Gail Williams, write that studies on a seven-valent (7PCV) and a nine-valent pneumococcal conjugate-vaccine (9PCV) in California and South Africa, respectively found similar results on the impact of the vaccine against pneumonia confirmed by chest x-ray. However, there is some uncertainty about the comparability of results because of different methods used in reading radiographs. The Gambian trial had a higher reduction of incidence of radiological pneumonia and is the first to show a reduction in hospital admissions and overall child mortality.


Story Source:

The above story is based on materials provided by Lancet. Note: Materials may be edited for content and length.


Cite This Page:

Lancet. "Vaccine Against Childhood Pneumonia Shows Promise." ScienceDaily. ScienceDaily, 1 June 2005. <www.sciencedaily.com/releases/2005/05/050528125159.htm>.
Lancet. (2005, June 1). Vaccine Against Childhood Pneumonia Shows Promise. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2005/05/050528125159.htm
Lancet. "Vaccine Against Childhood Pneumonia Shows Promise." ScienceDaily. www.sciencedaily.com/releases/2005/05/050528125159.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins